269-variant multiethnic genetic risk score

There is 1 paper on 269-variant multiethnic genetic risk score in aging research: 1 observational study in people. The newest story, Nov 12, 2026: “Prostate cancer gene scores add little beyond age in Black men”.

Biomarker

1 paper studies it1 finding

1 new paper in 30 daysSee all 1 papers on 269-variant multiethnic genetic risk score

“Adding the 269-variant multiethnic score to age in an integrated risk model improved discrimination in White men across all prediction horizons, increasing AUC by 8.69–11.23%.”
Current Prostate Cancer Genetic Risk Scores Add Limited Predictive Value for Black Men: a prospective cohort study in the UK Biobank and Our Future HealthResearch Square2026doi:10.21203/rs.3.rs-11373780/v1
  • Humans1

Effects

1

Prostate cancer prediction discrimination

upin humans1

1 study
  1. 269-variant multiethnic genetic risk score is linked with higher prostate cancer prediction discrimination in humans (White men; added to an age-based risk model) (AUC increased by 8.69–11.23%).

    “Adding the 269-variant multiethnic score to age in an integrated risk model improved discrimination in White men across all prediction horizons, increasing AUC by 8.69–11.23%.”

    HumansWhite men; added to an age-based risk model2, 5, and 10 yearsmales

    Prostate cancer gene scores add little beyond age in Black men

    Research SquarePreprint

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 11 paper in 12 months
Research Square

Prostate cancer gene scores add little beyond age in Black men

Adding genetic information to age improved a measure of prostate cancer prediction by 1.83% over 10 years in Black men, compared with age alone.Adding genetic information to age improved a measure of prostate cancer prediction by 1.83% over 10 years in Black men, compared with age alone.

Preprint: cohort studyProstate cancer